Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse
巡逻单核细胞在 HIV/药物滥用期间脑血管修复中的作用
基本信息
- 批准号:10557168
- 负责人:
- 金额:$ 14.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdoptive TransferAffectAreaAttenuatedBeliefBiological AssayBloodBlood - brain barrier anatomyBlood VesselsBlood brain barrier dysfunctionBrainCellsCerebrovascular systemCerebrumChemotaxisChronicClinicalCocaineCocaine UsersCollaborationsCommunicationCytoskeletonDataDrug usageEndotheliumEnvironmentEvaluationExtravasationFrequenciesHIVHIV SeropositivityHIV diagnosisHIV-associated neurocognitive disorderHemorrhageHomeostasisHumanImmuneImpairmentIn VitroIndividualInvadedKnock-outKnowledgeLateralMacrophageMaintenanceMediatingMicrofluidicsModelingPathogenesisPersonsPopulationPopulation HeterogeneityPrevalenceProcessProteinsRecoveryResearchRoleSamplingScanningSignal TransductionSpeedSubstance Use DisorderSubstance abuse problemSurfaceSurveysTestingTherapeuticTight JunctionsTimeUnited States Department of Veterans AffairsUniversitiesVascular EndotheliumViremiaVirus ReplicationWithdrawalantiretroviral therapyblood-brain barrier disruptionblood-brain barrier functionbrain endothelial cellbrain parenchymacerebrovascularcocaine exposurecocaine usecohortcomorbiditydrug of abuseextracellularextracellular vesiclesimmune cell infiltratein vitro Assayin vivoin vivo Modelinjuredinnovationintercellular communicationmicrovesiclesmonocyteneuroAIDSneuroinflammationneurovascular unitnovelpreservationrecruitrepairedresilienceresponserestorationsigma-1 receptortranscription factorvirtual
项目摘要
Abstract (30 lines or less)
HIV-associated neurocognitive disorders (HAND) remain a concern in the US and worldwide for the nearly 40
million people living with HIV. One of the hallmark features of HAND pathogenesis is the infiltration of immune
cells and viral replication in the brain. This process occurs in part due to a loss of blood-brain barrier (BBB)
integrity, which results in hyperpermeability and increased immune cell extravasation. Additionally, it is well
established that drugs of abuse can exacerbate HAND by augmenting blood-brain barrier (BBB) dysfunction
and neuroinflammation. The mechanisms that govern BBB resilience, or lack thereof, and recovery during
HIV/substance abuse remain understudied. This proposal is based on the central premise that understanding
these mechanisms could identify means to speed BBB recovery, attenuate immune cell infiltration and
ultimately slow the progression of HAND. We are focused on a subclass of immune cells, non-classical
monocytes or patrolling monocytes, that have been identified for their unique functions in vascular
maintenance and homeostasis. Patrolling monocytes have been shown to survey the luminal endothelial
surface, scavenge debris and initiate vascular repair. These processes are clearly positive effects that aid in
the preservation and recovery of the vasculature. However, the functions of these specialized cells have not
been studied in the context of substance abuse or HIV. We will test the central hypothesis that cocaine impairs
patrolling monocyte function and repair of the BBB. Additionally, we will also investigate the innovative concept
that the cerebral vascular endothelium communicates the need for vascular repair through extracellular
vesicles. We propose a multilateral approach that utilizes in vivo models, advanced in vitro microfluidic
modeling of the BBB, and analysis of clinical samples to understand the role and function of patrolling
monocytes in the context of HIV/substance abuse. Importantly, our use of advanced in vitro microfluidic
modeling of the BBB with primary human cells presents the opportunity to study endothelial-immune
interactions in a way that more closely mimics the human in vivo environment. Overall, the studies
encompassed in this proposal will advance current knowledge regarding patrolling monocyte function, cerebral
endothelial-immune interactions, and establish a novel mechanism by which drugs of abuse contributes to
HAND.
摘要(30行或以下)
艾滋病毒相关的神经认知障碍(HAND)仍然是美国和全球近40年来的一个问题。
100万艾滋病毒感染者。HAND发病机制的标志性特征之一是免疫细胞浸润,
细胞和病毒在大脑中的复制。这一过程的发生部分是由于血脑屏障(BBB)的丧失。
完整性,这导致高渗透性和增加的免疫细胞外渗。另外,
确定滥用药物可通过增加血脑屏障(BBB)功能障碍而加重HAND
和神经炎症。控制BBB弹性或缺乏弹性的机制,以及在
对艾滋病毒/药物滥用的研究仍然不足。这一建议的核心前提是,
这些机制可以确定加速BBB恢复,减弱免疫细胞浸润,
最终导致手的进展缓慢。我们专注于免疫细胞的一个亚类,非经典的
单核细胞或巡逻单核细胞,已被鉴定为它们在血管内皮细胞中的独特功能。
维持和体内平衡。巡逻单核细胞已被证明调查管腔内皮细胞
表面,清除碎片并启动血管修复。这些过程显然是积极的影响,
血管系统的保存和恢复然而,这些特化细胞的功能并没有
在药物滥用或艾滋病的背景下进行了研究。我们将检验可卡因损害
巡逻单核细胞功能和修复血脑屏障。此外,我们还将研究创新概念
脑血管内皮细胞通过细胞外信号传递血管修复的需要
囊泡我们提出了一个多边的方法,利用体内模型,先进的体外微流体
BBB的建模和临床样本的分析,以了解巡逻的作用和功能
单核细胞在HIV/药物滥用的背景下。重要的是,我们使用先进的体外微流体技术,
用原代人细胞模拟血脑屏障为研究内皮免疫功能提供了机会。
以更接近地模拟人类体内环境的方式相互作用。总体而言,研究
本提案所包含的内容将推进有关巡逻单核细胞功能、大脑功能的现有知识
内皮免疫相互作用,并建立一种新的机制,滥用药物有助于
手
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allison Michelle Andrews其他文献
Allison Michelle Andrews的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Allison Michelle Andrews', 18)}}的其他基金
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse
创新的原位成像技术,用于在药物滥用情况下可视化中枢神经系统相关的艾滋病毒储存库
- 批准号:
10682957 - 财政年份:2023
- 资助金额:
$ 14.99万 - 项目类别:
HIV and Cocaine Drive Bone-Marrow Blood (BMB) Barrier Dysfunction and Altered Hematopoietic Stem Cell (HSC) Differentiation Leading to Cardiovascular Disease
HIV 和可卡因导致骨髓血液 (BMB) 屏障功能障碍和造血干细胞 (HSC) 分化改变,导致心血管疾病
- 批准号:
10469745 - 财政年份:2022
- 资助金额:
$ 14.99万 - 项目类别:
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse
巡逻单核细胞在 HIV/药物滥用期间脑血管修复中的作用
- 批准号:
10331315 - 财政年份:2019
- 资助金额:
$ 14.99万 - 项目类别:
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse
巡逻单核细胞在 HIV/药物滥用期间脑血管修复中的作用
- 批准号:
10080722 - 财政年份:2019
- 资助金额:
$ 14.99万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 14.99万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 14.99万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 14.99万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 14.99万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 14.99万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 14.99万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 14.99万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 14.99万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 14.99万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 14.99万 - 项目类别: